Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus

about

Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults.Early metabolic markers identify potential targets for the prevention of type 2 diabetes

P2860

Q35664924-6A6700BF-4B12-4CDD-AAE1-380654838922 Q37403973-D636E3DD-B3A6-49EF-9550-A42BF238DE4C Q38673034-187FF8AC-5BEF-4007-B5AD-409C361FD352

P2860

Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus

Item

http://www.wikidata.org/entity/Q28541677

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Preclinical characterization o ...... t for type 2 diabetes mellitus

@ast

Preclinical characterization o ...... t for type 2 diabetes mellitus

@en

Preclinical characterization o ...... t for type 2 diabetes mellitus

@nl

type

Item

label

Preclinical characterization o ...... t for type 2 diabetes mellitus

@ast

Preclinical characterization o ...... t for type 2 diabetes mellitus

@en

Preclinical characterization o ...... t for type 2 diabetes mellitus

@nl

prefLabel

Preclinical characterization o ...... t for type 2 diabetes mellitus

@ast

Preclinical characterization o ...... t for type 2 diabetes mellitus

@en

Preclinical characterization o ...... t for type 2 diabetes mellitus

@nl

P1476

Preclinical characterization o ...... t for type 2 diabetes mellitus

@en

P2093

Abhijeet Nag

http://www.w3.org/2001/XMLSchema#string

Alexei Y Savinov

http://www.w3.org/2001/XMLSchema#string

Arvind Raghavan

http://www.w3.org/2001/XMLSchema#string

Christina Amatya

http://www.w3.org/2001/XMLSchema#string

Ilian A Radichev

http://www.w3.org/2001/XMLSchema#string

Jacob Ellefson

http://www.w3.org/2001/XMLSchema#string

Mark S Robbins

http://www.w3.org/2001/XMLSchema#string

Mark S Williams

http://www.w3.org/2001/XMLSchema#string

Matthew L Charles

http://www.w3.org/2001/XMLSchema#string

Tadeusz Kolodka

http://www.w3.org/2001/XMLSchema#string

P2860

The kallikrein-kinin system in diabetic nephropathy

Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway

Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia

Altered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genes

The kallikrein-kinin system in humans.

Kallikrein activates bradykinin B2 receptors in absence of kininogen.

The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity.

Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways

The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.

P304

e103981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0103981

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264637108

http://www.w3.org/2001/XMLSchema#string

P698

25100328

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4123992

http://www.w3.org/2001/XMLSchema#string

Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus

about

P2860

P2860

Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932